Here are the latest updates on the approval and upcoming sales of Presvu Eye Drops:
- Government Approval: The Drug Controller General of India (DCGI) has approved Presvu Eye Drops, developed by Entod Pharmaceuticals.
- Vision Improvement: These eye drops can improve vision within 15 minutes of application.
- Sales Launch: Presvu Eye Drops will be available for sale starting next month.
- Target Condition: The eye drops are designed to treat presbyopia, a common age-related vision problem.
- Market Impact: This approval marks a significant advancement in eye care innovation in India.
- Usage Benefits: Presvu Eye Drops aim to reduce the reliance on reading glasses for individuals with presbyopia.
- Product Availability: The eye drops will be launched in the domestic market in the first week of October.
- Global Reach: Entod Pharmaceuticals plans to expand the product to emerging markets such as Africa and Southeast Asia.
- Cost: The eye drops will be available at a cost of Rs 350 per bottle.
- Expert Opinion: Dr. Aditya Sethi highlighted that Presvu Eye Drops can significantly improve near vision, enhancing the quality of life for many.
-
EPFO’s One-Time Amnesty Scheme for Exempt Trusts Is Now Open — Over 100 Legal Cases Could Be Settled and Thousands of Workers Will Benefit
India’s retirement savings landscape just witnessed one of its most consequential policy decisions in years. The Central Board of Trustees (CBT) of the Employees’ Provident Fund Organisation (EPFO), at its landmark 239th meeting held on March 2, 2026, chaired by Union Minister Dr. Mansukh Mandaviya, formally approved a one-time Amnesty Scheme for exempted establishments. This…
-
Indian Stock Market Trends Today: Complete BSE Sensex, NSE Nifty 50 & Sector Analysis — Tuesday, 30 June 2026
Your exclusive, data-packed Indian market briefing for Tuesday, June 30, 2026 — the last trading day of Q1 FY27. What’s dragging the bulls down, and where are the smartest opportunities hiding right now? 📊 Market Snapshot: The State of Indian Equities Today The Indian stock market entered the final day of June 2026 carrying the…
-
EPF Interest Rate Stays at 8.25% for FY 2025–26 — Is This Good News or a Warning Sign for 7 Crore EPFO Subscribers?
For over seven crore salaried workers across India, the Employees’ Provident Fund is not just a deduction on their payslip — it is the financial backbone of their retirement. So when the Central Board of Trustees (CBT) of the Employees’ Provident Fund Organisation (EPFO) met on March 2, 2026, and decided to retain the EPF…
-
EPFO Launches Full Online KYC & e-Nomination Update Without Visiting Office — Millions of Inactive Accounts Could Be Reactivated by July
If you have an old EPF account sitting dormant because your KYC wasn’t updated or your nomination details were never filed — this news could change everything for you. The Employees’ Provident Fund Organisation (EPFO) has officially rolled out a fully digital process that allows members to complete KYC verification and update their e-Nomination entirely…
-
How to File TDS Form 121: A Practical Guide for Indian Taxpayers
Form 121 is the new declaration used to prevent TDS on certain incomes when your estimated tax liability is nil, and it replaces the older 15G and 15H framework under the Income-tax Rules, 2026. The right way to file it is simple: check eligibility, fill Part A with correct income and PAN details, submit it…
-
Indian Stock Market Trends Today — Monday 29 June 2026: Sensex, Nifty 50, Bank Nifty, GDP Outlook & Top Stocks to Buy Now
Is the Indian market at a make-or-break moment? With geopolitical tensions flaring, the RBI holding its repo rate at 5.25%, and domestic investors pumping record SIP flows into equities, June 29, 2026 opens as one of the most watched trading days of the year. Whether you’re a seasoned trader or a first-time investor trying to…
